NEWS RELEASE
TSX-PYT OTC-BB-PYNGF
Pyng Medical Receives Strong Support from US Military
The Committee on Tactical Combat Casualty Care Recommends F.A.S.T.1TM
Richmond, BC – January 21, 2005: Dr. Richard Clinchy, Director of Business Development for Pyng Medical Corp, Richmond, British Columbia, announced the receipt of a strong recommendation from the Committee on Tactical Casualty Combat Casualty Care (CoTCCC).
This recommendation is expected to have a sweeping impact on the use of the Pyng Medical F.A.S.T.1™ Intraosseous infusion system and lead to increased pace of adoption, not only in the military but also in civilian emergency medical services as well. The content of the committee’s position was approved by CAPT Frank Butler, Command Surgeon of USSOCOM and CAPT Steve Geibner of the US Navy and communicated directly to Pyng Medical. In all branches of the United States military there are approximately 90,000 medics that might ultimately utilize the F.A.S.T.1™ and in the civilian emergency medical services sector in the United States there are approximately 900,000 emergency medical technicians and paramedics.
The following is the communication from CoTCCC to Dr. Clinchy;
“The Committee on Tactical Combat Casualty Care (or CoTCCC) was commissioned in 2002 by the US Special Operations Command, and continued support of the Committee has come from the Navy Bureau of Medicine and Surgery (BUMED). The committee consists of 37 medical professionals from all branches of the military, the Public Health Service, the US Coast Guard, and selected civilian experts. Membership includes physicians, surgeons, and experienced combat medics.
At meetings of the CoTCCC held in December 2004, the subject of Intraosseous Infusion for vascular access in combat casualty care was reviewed. Of the available Intraosseous devices, the CoTCCC concluded that Pyng Medical Corp’s FAST-1™System for Adult Intraosseous Infusion with automatic depth control is the one best suited for the rigors of pre-hospital trauma care in tactical settings, and recommended it for issue to first responders providing care in such settings. This recommendation provides strong support for the wider use of the FAST-1® in both military and civilian emergency medical arenas.”
For further information contact:
Michael W. Jacobs, CEO, Pyng Medical Corp
1-604-303-7964 – 1-800-349-7964 - www.pyng.com
The Toronto Venture Exchange has neither reviewed nor approved of the contents of this News Release. Safe Harbor Statement: This release may contain certain forward-looking statements including without limitation, projections, assumptions, expectations, product development objectives, commercial introduction, and potential advantages of the F.A.S.T. 1 System. Actual events or results may differ from the Company's expectations as a result of risk factors discussed in Pyng Medical Corp. reports on file with the U.S. Securities and Exchange Commission, including, but not limited to, the Company's report on Form 20F for the year ended September 30, 2003. |
